Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023

Stock Price vs Company Growth
1d
0.3%
1w
0.3%
1m
5.3%
3m
18.1%
6m
12.0%
1y
0.5%
all
17.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,364 0.3%
1,910
2,640
Company Overview

Sales
14,278 Cr
Growth: 16.4%
Profit after Tax
1,913 Cr
Growth: 7.5%
Large Cap
97,612 Cr
P/E: 51.1x
Industry P/E: 31.3x
Fundamentals

Sales (Cr) ₹ 14,278
Growth 16.4%
EBITDA 25.3%
P/S 6.8x
Dividend 0.0%
P/E 51.1x
Book Value ₹ 395
PEG Ratio 3.1x
ROE 12.3%
P/B 6.0x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is India’s one of the leading pharmaceutical company with a diversified portfolio - from pharma and super specialty to consumer healthcare backed by strong in-house R&D capabilities with an established and deeply penetrated presence across India. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Investors (1)
Followers (2)